期刊文献+

绝经后高血压危险因素的Meta分析 被引量:1

Risk Factors for Postmenopausal Hypertension:a Meta-analysis
下载PDF
导出
摘要 背景流行病学研究表明,绝经后女性的高血压患病率高于老年男性。近年来,有关绝经后高血压的临床表现、病理特征、发病机制、治疗方法等受到越来越多的关注,但由于受到研究设计、样本量、人群特征、资源不足等因素的影响,其危险因素的研究结果不一致且缺乏全面报道。目的运用系统评价方式探讨女性绝经后高血压的危险因素,为更好地预防和管理绝经后高血压提供循证证据。方法于2022年1—5月,计算机检索中国知网、万方数据知识服务平台、中国生物医学文献服务系统、PubMed、EmBase、the Cochrane Library、Web of Science电子数据库,获取与绝经后高血压危险因素相关的队列及病例对照研究。检索时限为建库起至2022-05-20。由2名研究者独立根据纳入和排除标准筛选文献、提取资料,采用纽卡斯尔-渥太华量表(NOS)对所提取的文献进行偏倚风险评估,将得分≥6分(高质量)的文献纳入研究,最后采用RevMan 5.3对其进行Meta分析。结果共纳入10篇文献,5篇为队列研究,5篇为病例对照研究,共涉及16个危险因素,总样本量为34864,且均为高质量文献。Meta分析结果显示,绝经后高血压的危险因素包括高高敏C反应蛋白水平(hs-CRP)〔RR(95%CI)=1.38(1.04,1.83)〕、高龄〔OR(95%CI)=1.39(1.11,1.74)〕、高体质指数(BMI)〔OR(95%CI)=1.61(1.19,2.18)〕、高胆固醇水平〔OR(95%CI)=1.35(1.14,1.59)〕、高三酰甘油水平〔OR(95%CI)=2.17(1.03,4.59)〕、糖尿病史〔OR(95%CI)=1.70(1.27,2.27)〕,保护因素包括高脂联素水平〔RR(95%CI)=0.83(0.70,0.99)〕、高绝经年龄〔OR(95%CI)=0.90(0.82,0.98)〕(P<0.05)。结论高hs-CRP、高龄、高BMI、高胆固醇、高三酰甘油、患有糖尿病是绝经后高血压的独立危险因素,控制其中可控的危险因素可有效降低绝经后高血压的发生风险。 Background Epidemiological studies have demonstrated that the prevalence of hypertension is higher in postmenopausal women than in elderly men.Increasing attention has been paid to postmenopausal hypertension recently,involving its clinical manifestations,pathological features,pathogenesisand treatment.However,due to disparities in study design,sample size and population characteristics,as well as insufficient resources,the research results of risk factors for postmenopausal hypertension are inconsistent and incomprehensive.Objective To perform a systematic review of risk factors for postmenopausal hypertension,so as to provide evidence-based basis for better prevention and management of the disease.Methods From January to May 2022,the databases of CNKI,WanfangData,SinoMed,PubMed,EmBase,the Cochrane Library,and Web of Science were searched for cohort and case-control studies related to risk factors for postmenopausal hypertension from the establishment of the databases to May 20,2022.Studies were identified using the inclusion and exclusion criteria,then assessed in terms of quality using the Newcastle-Ottawa Scale(NOS),and those with NOS score≥6(high quality)were included.RevMan 5.3 was used for meta-analysis.Results Ten high-quality studies were included,5 of which were cohort studies,and the other 5 were case-control studies.Overall,16 potential risk factors for postmenopausal hypertension were identified in a total sample size of 34864.Meta-analysis showed that the risk factors for postmenopausal hypertension included elevated hs-CRP〔RR(95%CI)=1.38(1.04,1.83)〕,older age〔OR(95%CI)=1.39(1.11,1.74)〕,elevated BMI〔OR(95%CI)=1.61(1.19,2.18)〕,elevated total cholesterol〔OR(95%CI)=1.35(1.14,1.59)〕,elevated triglyceride〔OR(95%CI)=2.17(1.03,4.59)〕,history of diabetes〔OR(95%CI)=1.70(1.27,2.27)〕.The risk-reducing factors included high adiponectin〔RR(95%CI)=0.83(0.70,0.99)〕and advanced menopausal age〔OR(95%CI)=0.90(0.82,0.98)〕.Conclusion Older age,high levels of hs-CRP,BMI,total cholesterol,and triglyceride,and diabetes are independent risk factors for postmenopausal hypertension.Thus,controlling some of the above controllable factors may effectively decrease the risk of postmenopausal hypertension.
作者 刘霜雪 李琰华 张港玮 赵琳 LIU Shuangxue;LI Yanhua;ZHANG Gangwei;ZHAO Lin(The Second School of Clinical Medicine,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of General Medicine,the Second Affiliated Hospital of Zhejiang Chinese Medical University(Xinhua Hospital of Zhejiang Province),Hangzhou 310005,China)
出处 《中国全科医学》 CAS 北大核心 2023年第4期512-518,共7页 Chinese General Practice
关键词 高血压 绝经后期 危险因素 队列研究 病例对照 META分析 Hypertension Postmenopause Risk factors Cohort studies Case-control studies Meta-analysis
  • 相关文献

参考文献3

二级参考文献38

  • 1Maric-Bilkan C, Manigrasso MB. Sex differences in hypertension: contribution of the renin-angiotensin sys-tem. Gend Med, 2012, 9:287-291.
  • 2Hilgers RH, Oparil S, Wouters W, et al. Vasorelaxing effects of estetrol in rat arteries. J Endocrinol, 2012, 215:97-106.
  • 3Giguere V, Tremblay A, Tremblay GB. Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling. Steroids, 1998, 63:335-339.
  • 4Hodges YK, Richer JK, Horwitz KB, et al. Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation, 1999, 99:2688-2693.
  • 5Dresner-Pollak R, Kinnar T, Friedlander Y, et al. Estrogen receptor beta gene variant is associated with vascular dementia in elderly women. Genet Test Mol Biomarkers, 2009, 13:339-342.
  • 6Mansur Ade P, Nogueira CC, Strunz CM, et al. Geuetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res, 2005, 36:511-517.
  • 7Sowers MR, Jannausch ML, McConnell DS, et al. Endo-genous estradiol and its association with estrogen receptor gene polymorphisms. Am J Med, 2006, 119 : S16-S22.
  • 8Lombardi M, Mercuro G, Fini M, et al. Gender specific aspects of treatment of cardiovascular risk factors in primary and secondary pre- ventinn[J]. Fundarn Clin Pharrnacol, 2010, 54(24): 699-705.
  • 9ReckelhoffiF. Sex and gender differences in physiology and pathophysiology[J]. Steroids, 2010, 75(8): 745-746.
  • 10Sun Q, Shi L, Rimm EB, et al. Vitamin D intake and risk of cardiovas- cular disease in US men and women[J]. Am J Clin Nutr, 2011, 94(2): 534-542.

共引文献13

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部